MedicineOncologyPharmacologyCancer PharmacologyChemotherapyDna RepairChemotherapy ResistanceCytotoxic ChemotherapyDna Damage SignalingDna Repair In CarcinogenesisGenotoxic CarcinogenesisMalignant NeoplasmsAtaxia Telangiectasia And Rad3-related InhibitionBreast Cancer ChemotherapyDna Synthesis InhibitionNuclear Base Excision RepairOvarian Cancer ChemotherapyOxaliplatin-based TherapyPlatinum CompoundsPlatinum-based Agents
NER (nuclear excision repair system) by halting cisplatin-induced cell death by activation of ATM (ataxia telangiectasia mutated) pathway. Although treatment has been shown to be effective, many patients experience relapse due to drug resistance. As a result, other platinum compounds such as oxaliplatin and carboplatin have since been used and have shown some levels of effectiveness. In this review, the clinical applications of cisplatin are discussed with a special emphasis on its use in cancer chemotherapy.
72
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Global cancer statistics, 2012
Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.4K citations · Full text
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay, Hai‐Rim Shin, Freddie Bray et al. · International Journal of Cancer · 2010 · 21.4K citations
Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu et al. · CA A Cancer Journal for Clinicians · 2010 · 12.6K citations · Full text